OxTalks will soon move to the new Halo platform and will become 'Oxford Events.' There will be a need for an OxTalks freeze. This was previously planned for Friday 14th November – a new date will be shared as soon as it is available (full details will be available on the Staff Gateway).
In the meantime, the OxTalks site will remain active and events will continue to be published.
If staff have any questions about the Oxford Events launch, please contact halo@digital.ox.ac.uk
My background is in molecular biology/biotechnology and its application to complex multi-disciplinary projects both in industry and academia. I currently lead the Oxford Protein Production Facility-UK), an initiative of the University of Oxford, funded by the MRC and BBSRC at the Research Complex at Harwell. We work in partnership with academic groups across the UK on the production and crystallization of a wide variety of recombinant proteins of biomedical importance. Our research activity is focused on the expression and characterisation of protein: protein, and protein: ligand complexes. In particular, we have been investigating the interaction between β-lactam antibiotics (penicillins and cephalosporins) and their therapeutic target in gram negative bacteria (Sainsbury et al. 2011, van Berkel et al. 2013). Recent results point to the possibility of using structural information in the design of new inhibitors for the treatment of infections by antibiotic resistant bacteria (Ren et al 2016).
